Modification of intracellular free calcium in cultured A10 vascular smooth muscle cells by exogenous phosphatidic acid

Biochemical Pharmacology

Volumn 65, Issue 12, 2003, Pages 2091-2098

  Bhugra, Praveen ^a,b   Xu, Yan Jun ^a,b   Rathi, Satyajeet ^a,b   Dhalla, Naranjan S ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Ca2+ handling; Phosphatidic acid; Sarcoplasmic reticulum; SR Ca2+ ATPase; Vascular smooth muscle cell

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; BISINDOLYLMALEIMIDE; CALCIUM; CYCLOPIAZONIC ACID; DILTIAZEM; DIPHENYLCARBAMIC ACID 4 CARBOXY 2 NITROPHENYL ESTER; EGTAZIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDIC ACID; PHOSPHOLIPASE C; PROTEIN KINASE C; RECEPTOR BLOCKING AGENT; THAPSIGARGIN; UNCLASSIFIED DRUG; VERAPAMIL; XESTOSPONGIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CONCENTRATION RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0037716233     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00201-6     Document Type: Article

References (41)

1. English D., Garcia J.G.N., Brindley D.N. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49:2001;588-599.
2. 2+ and cardiac contractile force. Am. J. Physiol. Heart Circ. Physiol. 271:1996;H651-H659.
3. Harris R.A., Schmidt J., Hitzemann B.A., Hitzemann R.J. Phosphatidate as a molecular link between depolarization and neurotransmitter release in the brain. Science. 212:1981;1290-1291.
4. Ohsako S., Deguchi T. Stimulation by phosphatidic acid of calcium influx and cyclic GMP synthesis in neuroblastoma cells. J. Biol. Chem. 256:1981;10945-10948.
5. i levels in neonatal rat cardiomyocytes. Biochim. Biophys. Acta. 1440:1999;89-99.
6. Putney J.W. Jr., Weiss S.J., Van De Walle C.M., Haddas R.A. Is phosphatidic acid a calcium ionophore under neurohumoral control? Nature. 284:1980;345-347.
7. 2+ across phosphatidylcholine membranes. Nature. 305:1983;637-638.
8. 2+ in rabbit platelets. Biochem. Int. 26:1992;491-497.
9. Karaki H., Ozaki H., Hori M., Mitsui-Saito M., Amano K., Harada K., Miyamoto S., Nakazawa H., Won K.J., Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49:1997;157-230.
10. Kuriyama H., Kitamura K., Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol. Rev. 47:1995;387-473.
11. 2+ accumulation in cardiac sarcoplasmic reticulum. J. Biol. Chem. 265:1990;4302-4308.
12. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 264:1989;17816-17823.
13. 2+-ATPase. Proc. Natl. Acad. Sci. U.S.A. 87:1990;2466-2470.
14. Henry R.A., Boyce S.Y., Kurz T., Wolf R.A. Stimulation and binding of myocardial phospholipase C by phosphatidic acid. Am. J. Physiol. Cell Physiol. 269:1995;C349-C358.
15. Berridge M.K. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
16. Takei M., Ueno M., Endo K., Nakagawa H. Effect of NCDC, a protease inhibitor, on histamine release from rat peritoneal mast cells induced by anti-IgE. Biochem. Biophys. Res. Commun. 181:1991;1313-1322.
17. Gafni J., Munsch J.A., Lam T.H., Catlin M.C., Costa L.G., Molinski T.F., Pessah I.N. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron. 19:1997;723-733.
18. Ma H.T., Venkatachalam K., Parys J.B., Gill D.L. Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes. J. Biol. Chem. 277:2002;6915-6922.
19. Toullec D., Pianetti P., Coste H., Bellevergue P., Grandperret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide Gf-109203x is a selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
20. Paolucci L., Sinnett-Smith J., Rozengurt E. Lysophosphatidic acid rapidly induces protein kinase D activation through a pertussis toxin-sensitive pathway. Am. J. Physiol. Cell Physiol. 278:2000;C33-C39.
21. Kurz T., Wolf R.A., Corr P.B. Phosphatidic acid stimulates inositol 1,4,5-trisphosphate production in adult cardiac myocytes. Circ. Res. 72:1993;701-716.
22. Qualliotine-Mann D., Agwu D.E., Ellenburg M.D., McCall C.E., McPhail L.C. Phosphatidic acid and diacylglycerol synergize in a cell-free system for activation of NADPH oxidase from human neutrophils. J. Biol. Chem. 268:1993;23843-23849.
23. Siddiqui R.A., English D. Phosphatidic acid elicits calcium mobilization and actin polymerization through a tyrosine kinase-dependent process in human neutrophils: a mechanism for induction of chemotaxis. Biochim. Biophys. Acta. 1349:1997;81-95.
24. Gonzalez-Gronow M., Gawdi G., Pizzo S.V. Plasminogen activation stimulates an increase in intracellular calcium in human synovial fibroblasts. J. Biol. Chem. 268:1993;20791-20795.
25. Patel S., Joseph S.K., Thomas A.P. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium. 25:1999;247-264.
26. Sanders K.M. Invited review: mechanisms of calcium handling in smooth muscles. J. Appl. Physiol. 91:2001;1438-1449.
27. Saetrum Opgaard O., Nothacker H., Ehlert F.J., Krause D.N. Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur. J. Pharmacol. 406:2000;265-271.
28. Tostes R.C., Storm D.S., Chi D.H., Webb R.C. Intracellular calcium stores and oscillatory contractions in arteries from genetically hypertensive rats. Hypertens. Res. 19:1996;103-111.
29. 3) in porcine coronary artery. Life Sci. 55:1994;227-235.
30. i responses in neonatal rat cardiomyocytes. J. Cardiovasc. Pharmacol. 34:1999;540-546.
31. Stasek J.E. Jr., Natarajan V., Garcia J.G. Phosphatidic acid directly activates endothelial cell protein kinase C. Biochem. Biophys. Res. Commun. 191:1993;134-141.
32. 77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J. Cell Physiol. 153:1992;62-75.
33. Neusser M., Tepel M., Zidek W. Angiotensin II responses after protein kinase C activation in vascular smooth muscle cells of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 21:1993;749-753.
34. Caramelo C., Okada K., Tsai P., Schrier R.W. Phorbol esters and arginine vasopressin in vascular smooth muscle cell activation. Am. J. Physiol. 256:1989;F875-F881.
35. Mujumdar V.S., Hayden M.R., Tyagi S.C. Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. J. Cell Physiol. 183:2000;28-36.
36. 2+ waves by UTP in rat cerebral artery smooth muscle cells. Am. J. Physiol. 279:2000;C1528-C1539.
37. 2+ sensitivity as a key mechanism of PKC-induced constriction in pressurized cerebral arteries. Am. J. Physiol. 277:1999;H1178-H1188.
38. 2+ spark frequency in smooth muscle cells from cerebral arteries. Am. J. Physiol. 273:1997;C2090-C2095.
39. i elevation in rat cardiomyocytes. Br. J. Pharmacol. 108:1993;6-8.
40. Freeman E.J. The Ang II-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism. Arch. Biochem. Biophys. 374:2000;363-370.
41. Freeman E.J., Chisolm G.M., Tallant E.A. Role of calcium and protein kinase C in the activation of phospholipase D by angiotensin II in vascular smooth muscle cells. Arch. Biochem. Biophys. 319:1995;84-92.